Tanos, R., Karmali, D., Nalluri, S., & Goldsmith, K. C. (2016). Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma. BMC Cancer.
Čikaški stil citiranjaTanos, Rachel, Dipan Karmali, Srilatha Nalluri, i Kelly C. Goldsmith. "Select Bcl-2 Antagonism Restores Chemotherapy Sensitivity in High-risk Neuroblastoma." BMC Cancer 2016.
MLA način citiranjaTanos, Rachel, Dipan Karmali, Srilatha Nalluri, i Kelly C. Goldsmith. "Select Bcl-2 Antagonism Restores Chemotherapy Sensitivity in High-risk Neuroblastoma." BMC Cancer 2016.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.